Home › Funds › Clearline Capital LP › BLCO
Clearline Capital LP position in BLCO
BAUSCH PLUS LOMB CORP · Health Care
Clearline Capital LP reported holding 701,967 shares of BLCO (BAUSCH PLUS LOMB CORP) in its Q2 2026 13F filing — a position valued at US$11.6M, representing 0.69% of its reported portfolio and ranking #41 among its reported holdings. Clearline Capital LP has disclosed BLCO holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Clearline Capital LP's BLCO position evolved
Clearline Capital LP first disclosed a stake in BLCO in Q3 2023 at 247,445 shares (US$4.2M). The position peaked in Q4 2025 at 827,568 shares, worth US$14.1M. Across 12 filings, Clearline Capital LP increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 701,967 shares valued at US$11.6M. Notable position changes include a 137% increase in Q2 2024 (shares rose 33% over the following quarter), a 38% increase in Q1 2025 (shares fell 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 247.44K | $4.19M | New |
| Q4 2023 | 289.97K | $4.95M | Add |
| Q1 2024 | 300.65K | $5.20M | Add |
| Q2 2024 | 712.05K | $10.34M | Add |
| Q3 2024 | 710.05K | $13.70M | Hold |
| Q4 2024 | 646.64K | $11.68M | Reduce |
| Q1 2025 | 893.79K | $12.96M | Add |
| Q2 2025 | 913.51K | $11.88M | Add |
| Q3 2025 | 917.04K | $13.82M | Hold |
| Q4 2025 | 827.57K | $14.13M | Reduce |
| Q1 2026 | 701.97K | $11.16M | Reduce |
| Q2 2026 | 701.97K | $11.62M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BLCO and 13F data
BLCO (BAUSCH PLUS LOMB CORP) is a Health Care company. 24 other funds we track also report a position in BLCO — the largest reported positions include ICAHN CARL C (US$58.0M), OAKTREE CAPITAL MANAGEMENT LP (US$57.0M), Davidson Kempner Capital Management (US$52.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BLCO
- ICAHN CARL C 3.50M sh · $57.96M · Q2 2026
- OAKTREE CAPITAL MANAGEMENT LP 3.44M sh · $56.98M · Q2 2026
- Davidson Kempner Capital Management 3.16M sh · $52.31M · Q2 2026
- GOLDENTREE ASSET MANAGEMENT LP 2.66M sh · $43.96M · Q2 2026
- CASPIAN CAPITAL LP 2.00M sh · $33.10M · Q2 2026
- GLENVIEW CAPITAL MANAGEMENT, LLC 1.92M sh · $31.76M · Q2 2026
- CLARK ESTATES INC/NY 881.00K sh · $14.59M · Q2 2026
- GordonMD Global Investments LP 573.47K sh · $9.50M · Q2 2026
- Ratan Capital Management LP 383.71K sh · $6.35M · Q2 2026
More on Clearline Capital LP
FAQ
How long has Clearline Capital LP held BLCO?
Clearline Capital LP has disclosed BLCO holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Clearline Capital LP's current position in BLCO?
As of Q2 2026, Clearline Capital LP holds 701.97K shares of BLCO (BAUSCH PLUS LOMB CORP), valued at $11.62M, representing 0.69% of its reported portfolio and ranking #41.
Has Clearline Capital LP been buying or selling BLCO?
In the latest 13F filing (Q2 2026), Clearline Capital LP held unchanged its position in BLCO. The position peaked in Q4 2025 at 827.57K shares.
Which other funds hold BLCO?
Other major institutional holders of BLCO include ICAHN CARL C, OAKTREE CAPITAL MANAGEMENT LP, Davidson Kempner Capital Management, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.